Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
Hien K. Duong(Cleveland Clinic), Paul A. Carpenter(Fred Hutch Cancer Center), Steven M. Devine(National Marrow Donor Program), Paul Shaughnessy(CHRISTUS Transplant Institute), Ed Copelan(Carolinas Healthcare System), Navneet S. Majhail(Sarah Cannon), Mohamad Mohty(Sorbonne Université), Corey Cutler(Harvard University), Helen Leather(University of Florida), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Bipin N. Savani(Vanderbilt University Medical Center), Mark R. Litzow(Dana-Farber Cancer Institute), John R. Wingard(University of Florida Health), William Bensinger(Swedish Medical Center), Luciano J. Costa(University of Alabama at Birmingham)
Cited by 210
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k